Psychiatry Research - Feb 13, 2026
Back to Stakeholders
Categories
1 domain / 2 areas / 1 specialization
Massachusetts General Hospital
Data updated
United States
20 Trials1 Paper1 Event
The Center for the Neuroscience of Psychedelics aims to better understand how psychedelics can be used to improve the treatment of mental illnesses. The core mission of the center is to understand exactly how psychedelics enhance the brain's capacity for change—or neuroplasticity—to optimize current treatments and render the term treatment resistant obsolete.
Academic Research
1 papersPublished Papers
1
Trial Involvement
20
Distinct Focus Topics
0
Latest Publication
Feb 13, 2026
Recent Papers
Quick Facts
- Type
- hospital
- HQ
- United States
- Website
- Visit
Research Landscape
What the 20 registered trials Massachusetts General Hospital sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.
How fast is Massachusetts General Hospital research growing?
SourcedRegistered trials by recorded study-start year. Click a year for the running total.
Don't read as total research effort: only registered trials with a recorded start date are counted (20 of 20 tracked). Recent years under-count because of registration lag; striped bars are still filling in or are planned starts.
What's live right now, and what stopped?
SourcedRegistry status of all 20 Massachusetts General Hospital trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.
Which conditions does Massachusetts General Hospital run trials on?
SourcedTrials per primary indication. Orange marks the largest research focus.
Don't read shares as adding to 100%: a trial with several primary indications counts once per indication. Trial volume signals research attention, not evidence quality.
Which compounds appear in Massachusetts General Hospital trials?
SourcedTrials per compound. Orange marks the most-studied compound.
Don't read shares as adding to 100%: a trial testing several compounds counts once per compound, and placebo comparator arms are not shown. Trial volume signals research attention, not evidence quality.